Incyte (INCY) Non-Current Deffered Revenue (2010 - 2015)

Incyte (INCY) reported Non-Current Deffered Revenue of $2.9 million for Q3 2015, down 81.76% on a YoY basis from $15.7 million in Q3 2014, and down 52.84% quarter-over-quarter from $6.1 million in Q2 2015.

Incyte (INCY) Non-Current Deffered Revenue (2010 - 2015) Analysis & Trends

Incyte has reported Non-Current Deffered Revenue for 6 years, with the latest figure at $2.9 million in Q3 2015.

  • For the quarter ending Q3 2015, Non-Current Deffered Revenue fell 81.76% year-over-year to $2.9 million; the trailing twelve-month figure through Sep 2015 stood at $2.9 million (down 81.76% YoY), and the FY2014 full-year result was $12.5 million, down 50.68% from the prior year.
  • Non-Current Deffered Revenue for Q3 2015 stood at $2.9 million, down from $6.1 million in the prior quarter.
  • The five-year high for Non-Current Deffered Revenue was $154.5 million in Q1 2011, with the low at $2.9 million in Q3 2015.
  • Historically, Non-Current Deffered Revenue has averaged $51.4 million across 5 years, with a median of $31.8 million in 2013.
  • Annual changes were most pronounced in 2013 — Non-Current Deffered Revenue plunged 33.63% — and 2015, when it plunged 81.76%.
  • Incyte's Non-Current Deffered Revenue stood at $104.3 million in 2011, then slumped by 63.34% to $38.2 million in 2012, then slumped by 33.63% to $25.4 million in 2013, then plunged by 50.68% to $12.5 million in 2014, then sank by 77.07% to $2.9 million in 2015.
  • The last three Non-Current Deffered Revenue figures came in at $2.9 million (Q3 2015), $6.1 million (Q2 2015), and $9.3 million (Q1 2015), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Incyte 19.62 Bn 15.60 Bn 1.17 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2015 2.87 Mn
Jun 30, 2015 6.08 Mn
Mar 31, 2015 9.30 Mn
Dec 31, 2014 12.51 Mn
Sep 30, 2014 15.73 Mn
Jun 30, 2014 18.94 Mn
Mar 31, 2014 22.15 Mn
Dec 31, 2013 25.37 Mn
Sep 30, 2013 28.58 Mn
Jun 30, 2013 31.80 Mn
Mar 31, 2013 35.01 Mn
Dec 31, 2012 38.23 Mn
Sep 30, 2012 54.06 Mn
Jun 30, 2012 70.80 Mn
Mar 31, 2012 87.54 Mn
Dec 31, 2011 104.27 Mn
Sep 30, 2011 121.01 Mn
Jun 30, 2011 137.75 Mn
Mar 31, 2011 154.48 Mn
Dec 31, 2010 171.22 Mn